Evidence map›Paper›PMID 39872555›Full record

ArticleCureus2024

Successful Percutaneous Coronary Stenting in End-Stage Liver Disease Patients Awaiting Liver Transplantation.

Anoshia Raza, Philip Lim, Kajol Shah, Alexander Sudyn, Christine Gerula, Alfonso H Waller, Julius M Gardin, Marc Klapholz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anoshia RazaCardiology, Newark Beth Israel Medical Center, Newark, USA.
Philip LimMedicine, Rutgers University New Jersey Medical School, Newark, USA.
Kajol ShahMedicine/Cardiology, Rutgers University New Jersey Medical School, Newark, USA.
Alexander SudynInternal Medicine, Columbia University College of Physicians and Surgeons, New York, USA.
Christine GerulaMedicine/Cardiology, Rutgers University New Jersey Medical School, Newark, USA.
Alfonso H WallerMedicine/Cardiology, Rutgers University New Jersey Medical School, Newark, USA.
Julius M GardinMedicine/Cardiology, Rutgers University New Jersey Medical School, Newark, USA.
Marc KlapholzMedicine/Cardiology, Rutgers University New Jersey Medical School, Newark, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary artery disease (CAD) is associated with poor outcomes after orthotopic liver transplantation (OLT). We report on six high-risk end-stage liver disease (ESLD) patients who underwent percutaneous coronary intervention (PCI) with bare metal stents during the preoperative evaluation process. There was no mortality or major adverse cardiac event (MACE) within 90 days of OLT. These patients had advanced models for end-stage liver disease sodium (MELD-Na) scores (mean 24.5), thrombocytopenia (mean 70,500 µL⁻¹), and elevated international normalized ratio (INR; mean 2.0), who tolerated stent implantation followed by modified antiplatelet regimens. Percutaneous coronary intervention may facilitate listing with good OLT outcomes.

Indexed as

coronary artery angiographycoronary stentsliver transplant risk stratificationorthotropic liver transplantprimary percutaneous coronary intervention (pci)

Identifiers

PMID39872555
PMCPMC11771528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.